Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Dec 10:6:1475498.
doi: 10.3389/frph.2024.1475498. eCollection 2024.

Global, regional, and national burden of HIV and tuberculosis and predictions by Bayesian age-period-cohort analysis: a systematic analysis for the global burden of disease study 2021

Affiliations

Global, regional, and national burden of HIV and tuberculosis and predictions by Bayesian age-period-cohort analysis: a systematic analysis for the global burden of disease study 2021

Xuebin Tian et al. Front Reprod Health. .

Abstract

Objective: To assess sex, age, regional differences, and the changing trend in human immunodeficiency virus and tuberculosis (HIV-TB) in different regions from 1990 to 2021, and project future trends.

Methods: Global Burden of Disease Study 2021 data were analyzed to assess HIV-TB incidence, death, prevalence, and DALY rates from 1990 to 2021, including different types of TB co-infections (drug-susceptible, multidrug-resistant, and extensively drug-resistant). Bayesian age-period-cohort models were used to forecast age-standardized DALY rates through 2035.

Results: In 2021, there were approximately 1.76 million HIV-TB infections and 200,895 deaths globally. The highest burden of HIV-DS-TB and HIV-MDR-TB was found in Southern Sub-Saharan Africa, while HIV-XDR-TB was most prevalent in Eastern Europe. The co-infection burden was highest among individuals aged 30-49. Key risk factors were unsafe sex, drug use, and intimate partner violence, with regional variations. The global burden of HIV-TB remains high, and age-standardized DALY rates are expected to increase in the coming years, especially in regions with low socio-demographic indices (SDI).

Conclusion: The burden of HIV-TB co-infection correlates with the socio-demographic index (SDI): countries with a low SDI have a higher burden. Therefore, clinical diagnosis and treatment in such areas are more challenging and may warrant more attention. High death rates underscore the importance of early management.

Keywords: Bayesian age-period-cohort; age-standardized rate; disability-adjusted life years; disease burden; human immunodeficiency virus and tuberculosis.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
(a) Age-standardized DALY rates of HIV-DS-TB, (b) age-standardized DALY rates of HIV-MDR-TB, (c) age-standardized DALY rates of HIV-XDR-TB per 100,000 cases in 2021 by country. DALY, disability-adjusted life year; HIV-DS-TB, HIV/AIDS-drug-susceptible tuberculosis; HIV-MDR-TB, HIV/AIDS-multidrug-resistant tuberculosis without extensive drug resistance; HIV-XDR-TB, HIV-AIDS-extensively drug-resistant tuberculosis.
Figure 2
Figure 2
(a) Age-standardized incidence, prevalence, death, and DALY rate by global, high SDI, high-middle SDI, middle SDI, low-middle SDI, and low SDI in HIV-DS-TB from 1990 to 2021. (b) Age-standardized incidence, prevalence, death, and DALY rate by global, high SDI, high-middle SDI, middle SDI, low-middle SDI, and low SDI in HIV-MDR-TB from 1990 to 2021. (c) Age-standardized incidence, prevalence, deaths and DALY rate by global, high SDI, high-middle SDI, middle SDI, low-middle SDI, and low SDI in HIV-XDR-TB from 1990 to 2021. SDI, socio-demographic index.
Figure 3
Figure 3
(a) Age-standardized incidence rate, (b) age-standardized prevalence rate, (c) age-standardized deaths rate, and (d) age-standardized DALY rate of HIV-DS-TB, HIV-MDR-TB, and HIV-XDR-TB in 21 disease burden regions in 2021.
Figure 4
Figure 4
(a) Female and male age-standardized DALY rate by age in global in 2021. (b) Female and male age-standardized DALY rate by age in high SDI in 2021. (c) Female and male age-standardized DALY rate by age in high-middle SDI in 2021. (d) Female and male age-standardized DALY rate by age in middle SDI in 2021. (e) Female and male age-standardized DALY rate by age in Low-middle SDI in 2021. (f) Female and male age-standardized DALY rate by age in low SDI in 2021.
Figure 5
Figure 5
Risk factor analysis for (a) HIV-DS-TB, (b) HIV-MDR-TB and (c) HIV-XDR-TB in global and SDI regions in 2021.
Figure 6
Figure 6
Trends in age-standardized DALY rates from 2021 to 2035 for (a) HIV-DS-TB, (b) HIV-MDR-TB, and (c) HIV-XDR-TB predicted by Bayesian age–period–cohort (BAPC) models.

Similar articles

References

    1. Collaborators GBDT. Global, regional, and national sex differences in the global burden of tuberculosis by HIV status, 1990–2019: results from the global burden of disease study 2019. Lancet Infect Dis. (2022) 22(2):222–41. 10.1016/S1473-3099(21)00449-7 - DOI - PMC - PubMed
    1. Ma J, Vongpradith A, Ledesma JR, Novotney A, Yi S, Lim K, et al. Progress towards the 2020 milestones of the end TB strategy in Cambodia: estimates of age and sex specific TB incidence and mortality from the global burden of disease study 2019. BMC Infect Dis. (2022) 22(1):904. 10.1186/s12879-022-07891-5 - DOI - PMC - PubMed
    1. Owiti P, Onyango D, Momanyi R, Harries AD. Screening and testing for tuberculosis among the HIV-infected: outcomes from a large HIV programme in western Kenya. BMC Public Health. (2019) 19(1):29. 10.1186/s12889-018-6334-4 - DOI - PMC - PubMed
    1. Rewari BB, Kumar A, Mandal PP, Puri AK. HIV TB coinfection - perspectives from India. Expert Rev Respir Med. (2021) 15(7):911–30. 10.1080/17476348.2021.1921577 - DOI - PubMed
    1. DeRiemer K, Kawamura LM, Hopewell PC, Daley CL. Quantitative impact of human immunodeficiency virus infection on tuberculosis dynamics. Am J Respir Crit Care Med. (2007) 176(9):936–44. 10.1164/rccm.200603-440OC - DOI - PMC - PubMed

LinkOut - more resources